Biortica plays down further delay to Bod Sciences deal by Steve Jones March 20, 2025March 20, 2025 Plans put forward by Biortica Agrimed to reverse takeover Bod Science and become a publicly listed […]
AMA renews attack on industry as South Australia now raises concerns by Steve Jones March 20, 2025March 20, 2025
ODC pledges to limit hike in annual fees despite fall in number of licence holders by Steve Jones March 19, 2025March 21, 2025
No buyers found for OneLife facility as director draws up financial plan by Steve Jones March 19, 2025March 19, 2025
InhaleRx eyes big pharma deal and ponders product launch through SAS by Steve Jones March 18, 2025March 18, 2025
‘It’s not the right time for a new venture’: Biortica out of running for OneLife facility by Steve Jones March 12, 2025March 13, 2025
Cultivator launches second capital raise to fund post-harvest processing by Steve Jones March 12, 2025March 13, 2025
Medigrowth raises $1.3m as Birchal campaign prepares to close by Steve Jones March 12, 2025March 13, 2025
Altum becomes latest to target cost-conscious patients with launch of budget brand by Steve Jones March 11, 2025March 13, 2025
Avecho vision takes shape as CEO flags ‘monster’ OTC opportunity by Steve Jones March 11, 2025April 29, 2026
